Form 6-K NATUZZI S P A For: Sep 14
http://archive.fast-edgar.com/20260914/AQ2VD62FZZ2ROZZZ2RZN2ZYS8NQQZZ22Z28G
Filed on: September 14, 2026
Form 6-K TRX GOLD Corp For: Sep 14
http://archive.fast-edgar.com/20260914/AN22Q22CZ22ED2YU222N22E2QOOA6Z22Z282
Filed on: September 14, 2026
Form 4 Hepion Pharmaceuticals, For: Sep 03 Filed by: LoPriore Vincent S
http://archive.fast-edgar.com/20260914/A322822CZZ2RV9T2229A2ZY2VCVK7Z22Q282
Filed on: September 14, 2026
Form 6-K TAKEDA PHARMACEUTICAL For: Sep 14
FORM 6-KU.S. SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Report of Foreign Private IssuerPursuant to Rule 13a-16 or 15d-16 ofthe Securities Exchange Act of 1934For the month of September 2026 Commission File Number: 001-38757TAKEDA PHARMACEUTICAL COMPANY LIMITED(Translation of registrant’s name into English)1-1, Nihonbashi-Honcho 2-ChomeChuo-ku, Tokyo 103-8668Japan(Address of principal executive offices)Indicate by check mark whether the registrant files... (continue reading...)
Form 6-K PRUDENTIAL PLC For: Sep 14
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the
month of September, 2026
PRUDENTIAL PUBLIC LIMITED COMPANY
(Translation
of registrant's name into English)
15/F, One International Finance Centre,
1 Harbour View Street, Central,
Hong Kong, China
(Address
of principal executive... (continue reading...)
More SEC Filings
View Older Stories-
Form D/A Bin Yuan Greater China
-
Form 424B2 AMERICAN INTERNATIONAL
-
Form 497K HARDING LOEVNER FUNDS
-
Form 8-K ADDENTAX GROUP CORP. For: Sep 14
-
Form 8-K Perspective Therapeutics For: Sep 14
-
Form 497K HARDING LOEVNER FUNDS
-
Form 6-K VinFast Auto Ltd. For: Sep 14
-
Form 497 HARDING LOEVNER FUNDS
-
Form 424B2 Vistra Operations Co
-
Form 8-K Embrace Change Acquisiti For: Sep 10
-
Form 8-K Lipocine Inc. For: Sep 14
-
Form D/A Bin Yuan Greater China
-
Form D/A L&R ASIA CREDIT ALPHA
-
Form 6-K NOVONIX Ltd For: Sep 14
-
Form 6-K Radiopharm Theranostics For: Sep 14
-
Form 425 Translational Developmen Filed by: Prologium Holding Inc.
-
Form 6-K Zhihu Inc. For: Sep 14
-
Form 6-K Clearmind Medicine Inc. For: Sep 14
-
Form F-3 Radiopharm Theranostics
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K Li Auto Inc. For: Sep 14
-
Form D/A Sage Partners Alpha 1
-
Form SCHEDULE 13G/A Grab Holdings Ltd Filed by: TOYOTA MOTOR CORP/
-
Form 3 Polar Power, Inc. For: Aug 17 Filed by: Ahern Jim
-
Form SCHEDULE 13G Safe Pro Group Inc. Filed by: FROST PHILLIP MD ET AL
-
Form 8-K WhiteFiber, Inc. For: Sep 14
-
Form 6-K PRUDENTIAL PLC For: Sep 14
-
Form S-1/A Electra Therapeutics,
-
Form 4 Alibaba Group Holding For: Sep 10 Filed by: Wu Yongming
-
Form 1-SA McQueen Labs Series, For: Jun 30
-
Form C/A Oravanti Ventures Inc
-
Form S-3ASR Tyra Biosciences, Inc.
-
Form DEF 14C SHARING ECONOMY INTERNAT For: Sep 14
-
Form 424B2 Jefferies Financial Grou
-
Form 6-K WOODSIDE ENERGY GROUP For: Sep 14
-
Form 15-12G Apogee Therapeutics,
-
Form 8-K Artificial Intelligence For: Sep 14
-
Form EFFECT ACCURAY INC
-
Form 6-K Biophytis SA For: Sep 11
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 6-K KE Holdings Inc. For: Sep 14
-
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
-
Form EFFECT Eightco Holdings Inc.
-
Form EFFECT Wheeler Real Estate Inve
-
Form 6-K Nanobiotix S.A. For: Sep 14
-
Form EFFECT Strategic Storage Trust
-
Form EFFECT VS MEDIA Holdings Ltd
